ROBBIE STAMARIA: Open Payments
NPI 1275155319 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 12 payments from 4 companies in 2025. Trend: 2023 $757 · 2024 $507 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $299 |
| AstraZeneca Pharmaceuticals LP | 3 | $248 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| Novo Nordisk Inc | 1 | $18 |
Products named: ZEPBOUND, BREZTRI, FARXIGA, TRELEGY ELLIPTA, MOUNJARO.
Industry payments across TX — which companies pay providers there.
